TG103

· CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TG103, covering 2022-05-23 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study of TG103 Injection Combined With Metformin in Treatment of Type 2 Diabetes Mellitus [Phase 3]